Steven Lauder

Steven Lauder is an experienced clinical research professional with a focus on managing global studies in rare diseases and cardiovascular therapies. Currently serving as a Freelance Global Study Manager at Intercept Pharmaceuticals, Steven oversees the operational aspects of phase 3 clinical studies, specifically in Primary Biliary Cholangitis. Previous roles include managing extensive cardiovascular studies across multiple regions at GlaxoSmithKline and working as a Clinical Project Manager at Pfizer, where responsibilities encompassed study feasibility, budgeting, and vendor management. Steven also has a background in osteopathy, having practiced as a Registered Osteopath with a specialization in sports injuries and care for expectant mothers. Educational credentials include a Master's degree in Osteopathic Medicine from the University College of Osteopathy and a Bachelor of Science in Applied Biochemistry from Brunel University London.